B Clay Siegall

Affiliations

  • Director at Tourmaline Bio Inc. (TRML), 2025-06-06
  • President And Ceo at Immunome Inc. (IMNM), 2025-03-26
  • at Shattuck Labs Inc. (STTK), 2024-06-21
  • President & Ceo at Seagen Inc. (SGEN), 2022-05-13
  • Director at Nurix Therapeutics Inc. (NRIX), 2022-05-06
  • Director at Ultragenyx Pharmaceutical Inc. (RARE), 2020-08-11
  • Director at Alder Biopharmaceuticals Inc (ALDR), 2019-10-24
  • Director at Mirna Therapeutics Inc. (MIRN), 2016-09-06
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IMNM $7.29 137,100 $999,459.00 806,736 2025-03-26 Filing
IMNM $7.75 150,000 $1,162,500.00 669,636 2025-01-31 Filing
IMNM $9.78 33,943 $331,918.41 519,636 2024-11-22 Filing
IMNM $9.54 66,057 $630,263.05 485,693 2024-11-21 Filing
IMNM $13.78 20,434 $281,547.83 419,636 2024-05-21 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SGEN $125.39 10,593 $1,328,256.27 666,060 2022-05-12 Filing
SGEN $126.18 6,450 $813,861.00 666,060 2022-05-12 Filing
SGEN $144.32 1,885 $272,040.56 666,060 2022-04-20 Filing
SGEN $157.23 474 $74,527.02 667,945 2022-04-07 Filing
SGEN $156.48 1,900 $297,312.00 667,945 2022-04-07 Filing